Literature DB >> 33371337

Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary Fibrosis.

Sheau-Ning Yang1,2, Diahn-Warng Perng3,4, Hsin-Kuo Ko3,4, Yuh-Lih Chang1,5, Chia-Chen Hsu1,5, Hsin-Yi Huang6,7, Mei-Ing Chung2.   

Abstract

Several databases of epidemiologic studies in patients with idiopathic pulmonary fibrosis (IPF) have been analyzed in the Western community. However, few studies have been reported in Asia. The objective of this study was to investigate the epidemiology of IPF in Taiwan. We collected and analyzed patients with IPF from the Taiwan National Health Insurance Research Database from 2001 to 2011. We estimated the annual incidence and cumulative prevalence of IPF and mean survival time of patients and determined the causes of death. The annual incidence rates of IPF remained stable after 2005, ranging from 0.7 to 1.3 cases per 100,000 people per year, whereas the cumulative prevalence rates increased steadily from 3.1 to 6.4 cases per 100,000 people per year during 2006-2011 based on a narrow case definition. Men older than 75 years had higher incidence compared with other age groups. The mean survival after diagnosis was 6.9 years. Old age, male sex, and respiratory hospitalization were associated with shorter survival time after diagnosis. Both the incidence and prevalence rates of IPF were lower in Taiwanese patients than Western ones. Moreover, the survival time was higher in the Asian population compared with the Western population. These results may suggest the heterogeneity of the IPF definition in different study populations and geographic locations.

Entities:  

Keywords:  Taiwan; idiopathic pulmonary fibrosis; incidence; prevalence

Year:  2020        PMID: 33371337      PMCID: PMC7767390          DOI: 10.3390/healthcare8040580

Source DB:  PubMed          Journal:  Healthcare (Basel)        ISSN: 2227-9032


  5 in total

1.  Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay.

Authors:  Jun-Jun Yeh; Shih-Hueh Syue; Yi-Fun Sun; Yi-Ting Yeh; Ya-Chi Zheng; Cheng-Li Lin; Chung Y Hsu; Chia-Hung Kao
Journal:  Biomedicines       Date:  2022-05-31

2.  Colchicine Is a Weapon for Managing the Heart Disease Among Interstitial Lung Disease With Viral Infection: Have We Found the Holy Grail?

Authors:  Jun-Jun Yeh; Tuey-Wen Hung; Cheng-Li Lin; Tsung-Tse Chen; Pei-Xuan Liw; Ya-Lun Yu; Chia-Hung Kao
Journal:  Front Cardiovasc Med       Date:  2022-06-28

3.  The effect of additional antimicrobial therapy on the outcomes of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Authors:  Ching-Yi Chen; Chao-Hsien Chen; Cheng-Yi Wang; Chih-Cheng Lai; Chien-Ming Chao; Yu-Feng Wei
Journal:  Respir Res       Date:  2021-09-15

4.  Occurrence of Idiopathic Pulmonary Fibrosis in Italy: Latest Evidence from Real-World Data.

Authors:  Marica Iommi; Martina Bonifazi; Andrea Faragalli; Lara Letizia Latini; Federico Mei; Liana Spazzafumo; Edlira Skrami; Luigi Ferrante; Flavia Carle; Rosaria Gesuita
Journal:  Int J Environ Res Public Health       Date:  2022-02-22       Impact factor: 3.390

Review 5.  Global incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Toby M Maher; Elisabeth Bendstrup; Louis Dron; Jonathan Langley; Gerald Smith; Javaria Mona Khalid; Haridarshan Patel; Michael Kreuter
Journal:  Respir Res       Date:  2021-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.